doxorubicin 通过相位分离催化 p53 的自我组装
Ankush Garg1, Gaurav Kumar1, Varinder Singh2
1Chemical Biology Unit, Institute of Nano Science and Technology, Sector- 81, Mohali (SAS Nagar), Punjab, 140306, India.
Current research in structural biology
|March 4, 2024
概括
doxorubicin 通过液-液相分离触发异常的 p53 蛋白自组,这可能解释了 p53.3 突变癌症的化疗耐药性. 这个过程涉及药物诱导的蛋白质聚合.
科学领域:
- 细胞生物学 细胞生物学
- 生物物理学的生物物理.
- 分子瘤学分子瘤学
背景情况:
- 液-液相分离 (LLPS) 对细胞功能至关重要,形成没有膜的有机体.
- 外部因素在LLPS和疾病,特别是癌症中的作用尚未得到充分研究.
- p53蛋白聚合与癌症的发展和治疗耐药性有关.
研究的目的:
- 为了研究 doxorubicin,一个外源刺激,对p53自组装的影响.
- 探索具有突变p53.3的癌细胞中化学抵抗的机制.
- 阐明LLPS在多克索鲁比诱导的p53聚合中的作用.
主要方法:
- 利用生物物理技术和成像来研究p53-doxorubicin相互作用.
- 在体外实验中对野生类型的p53 (WTp53) 和其N终端删除形式 (WTp53ΔNterm) 进行了实验.
- 分析了p53变体,包括在R273位置上的变体,用于相隔倾向.
主要成果:
- 多克索鲁比与WTp53及其突变形式同时局部化.
- 多克索鲁比辛在体外诱导LLPS和WTp53ΔNterm的聚合.
- 在R273的p53变体自发相位分离,表明突变诱导的不稳定.
结论:
- 多克索鲁比与p53的相互作用和凝结物内的局部化可能会导致化疗耐药性.
- 像多克索鲁比这样的外源药物可以诱导相分离和p53聚合.
- LLPS是一个关键的机制,将多克索鲁比辛治疗与p53聚合和潜在的化学抵抗联系起来.
相关概念视频
DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
Anaphase Promoting Complex
2.9K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.9K
Separation of Sister Chromatids
3.6K
At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
At the onset of anaphase, separase, a proteolytic enzyme, is...
3.6K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K


